rs141217974
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001010892.3(RSPH4A):c.1121G>A(p.Arg374His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000427 in 1,614,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R374C) has been classified as Uncertain significance.
Frequency
Consequence
NM_001010892.3 missense
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 11Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RSPH4A | NM_001010892.3 | c.1121G>A | p.Arg374His | missense_variant | Exon 3 of 6 | ENST00000229554.10 | NP_001010892.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RSPH4A | ENST00000229554.10 | c.1121G>A | p.Arg374His | missense_variant | Exon 3 of 6 | 1 | NM_001010892.3 | ENSP00000229554.5 | ||
| RSPH4A | ENST00000368581.8 | c.1121G>A | p.Arg374His | missense_variant | Exon 3 of 5 | 1 | ENSP00000357570.4 | |||
| RSPH4A | ENST00000368580.4 | c.922-1739G>A | intron_variant | Intron 2 of 4 | 5 | ENSP00000357569.4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152126Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000517 AC: 13AN: 251354 AF XY: 0.0000294 show subpopulations
GnomAD4 exome AF: 0.0000451 AC: 66AN: 1461856Hom.: 0 Cov.: 32 AF XY: 0.0000523 AC XY: 38AN XY: 727232 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152244Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74444 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Arg374His var iant in RSPH4A has not been previously identified in individuals with pulmonary disease, but has been identified in 6/66694 European chromosomes by the Exome Ag gregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs141217974). The affected amino acid is not well conserved in evolution with several mammalia n and bird species carrying the variant. This suggests that this variant may be tolerated. In summary, the clinical significance of the p.Arg374His variant is uncertain although it is suspected to be more likely benign.
Primary ciliary dyskinesia Uncertain:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 374 of the RSPH4A protein (p.Arg374His). This variant is present in population databases (rs141217974, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with RSPH4A-related conditions. ClinVar contains an entry for this variant (Variation ID: 229204). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The histidine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at